|
PRESS BRIEFING: Revolutionary Blood Test For Early And Accurate Diagnosis Of TB
August 05, 2004When?
Thursday 12th August, 9am (breakfast will be provided)
What?
The launch, by Oxford Immunotec, of the revolutionary T SPOT-TB test for the early and accurate detection and diagnosis of tuberculosis, which has recently received regulatory approval for sale across Europe.
A leading panel of experts, including Professor Peter Davies (Director of the Tuberculosis Research and Resources Unit, Liverpool), Paul Sommerfeld (Chair of TB Alert) and Dr Ajit Lalvani (Wellcome Senior Research Fellow, University of Oxford, the inventor of the T SPOT test) will discuss the growing problem of TB, issues around current diagnosis and the potential impact of the T SPOT-TB test on the management, control and treatment of TB. The panel will be chaired by Dr Peter Wrighton-Smith, CEO of Oxford Immunotec.
Where?
The British Medical Association, BMA House, Tavistock Square, London, WC1H 9JP
Why?
The new T SPOT-TB test represents a breakthrough in diagnostic testing and is set to revolutionise TB care at a time when concerns about the persistence and resurgence of TB are being raised. It is designed to replace the crude, 100 year old tuberculin skin test, bringing TB testing into the 21st century and making it available to many new patient groups where the skin test gives poor or meaningless results.
Northbank Communications
Tuberculosis News and Current Tuberculosis Events RSSNew Electrostatic-based DNA Microarray Technique Could Revolutionize Medical Diagnostics
The dream of personalized medicine - in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile - may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics.
Predicting TB outbreaks based on the first 2 cases
Outbreaks of tuberculosis (TB) may be able to be identified by looking at certain characteristics of the first two patients, according to new research.
Radical reform is needed to stop the 'inhumane' practice of transplant tourism
The UK government must bring in presumed consent to organ donation or allow a controlled donor compensation programme for unrelated live donors, in order to bring the "inhumane" practice of transplant tourism from the UK to an end, claims a doctor in this week's BMJ.
Pitt-led Researchers Find Source of Drug-Tolerant Tuberculosis Possibly Behind TB Relapses, Intensity of Treatment
University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in "Molecular Microbiology."
US soldiers in high-tuberculosis areas face new epidemic: false positives
U.S. Army service members are increasingly deployed in regions of the world where tuberculosis (TB) is rampant, such as Iraq and Afghanistan, and the military now faces a growing medical problem.
Tuberculosis not the only risk from new immunological drugs
A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis.
Pilot study reinforces use of portable anteroom HEPA filtration
Amidst an increase in new tuberculosis cases, researchers have begun investigating the effectiveness of new operating room filtration systems designed to protect staff and patients.
X-rays power discoveries at Chicago's Field Museum
Digital medical imaging and information technology from Carestream Health, Inc., is playing a key role in helping The Field Museum of Chicago discover and analyze secrets hidden within its world-class collections.
Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online.
NIAID describes research priorities to fight drug-resistant tuberculosis
Tuberculosis (TB) has long been one of the world's great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate.
More Tuberculosis News Articles
 | The Air We Breathe: A Novel by Andrea Barrett |
 | Illness as Metaphor and AIDS and Its Metaphors by Susan Sontag |
 | Towns of the Sandia Mountains (NM) (Images of America) by Mike Smith |
 | The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease by CHARLOTTE ROBERTS, JANE BUIKSTRA |
 | Basic Infection Control for Healthcare Providers by Michael Kennamer |
 | The Night Journal by Elizabeth Crook |
 | The Air We Breathe: A Novel by Andrea Barrett |
 | Harvey Girl by Sheila Wood Foard |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | Identification Problems in the Social Sciences by Charles F. Manski |
| © 2008 BrightSurf.com |